ArticleFrontiers in immunology2017

Targeting the Human T-Cell Inducible COStimulator Molecule with a Monoclonal Antibody Prevents Graft-vs-Host Disease and Preserves Graft vs Leukemia in a Xenograft Murine Model.

Aude Burlion et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.